Month: November 2021

Rates of hepatitis C virus (HCV) infections fell to 0.6% among gay and bisexual men living with HIV after a systematic HCV elimination campaign, showing that micro-elimination campaigns paired with continued testing and treatment is effective in addressing the HCV epidemic, said Katharina Kusejko, PhD, head of the data center of the Swiss HIV Cohort Study
0 Comments
In the treatment of Helicobacter pylori infection, combination therapies using the oral potassium-competitive acid blocker vonoprazan were superior to standard proton pump inhibitor (PPI)–based triple therapy, producing higher eradication rates, according to combined data from a U.S. and a European phase 3 randomized, controlled trial. Vonoprazan has been submitted to the Food and Drug Administration for approval
0 Comments
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health outcomes, and helped them feel more socially connected, an important benefit during the pandemic when many people have chosen to avoid in-person exercise
0 Comments
Open enrollment season is underway. With millions of employees reevaluating their job or considering a change, employer-sponsored benefits are an even greater consideration heading into 2022. About 157 million Americans rely on employer-sponsored health insurance coverage and yet, before the Covid-19 pandemic, many people spent very little time reviewing their workplace health-care plan during the
0 Comments
The dual orexin receptor antagonist lemborexant (Dayvigo) consistently helped patients with insomnia, including those with a history of depression, according to a phase III randomized study and a post-hoc analysis. Using the self-report Patient Global Impression-Insomnia scale, more than 70% of participants said that 5-mg or 10-mg lemborexant helped them sleep at night at months
0 Comments
Charlene Douglas, AKA The Intimacy Coach, shares her thoughts on love, sex, and making time to connect on Happiful’s podcast I am. I have Psychodynamic Counsellor and Psychosexual Therapist Charlene Douglas is doing all that she can to help people address their concerns and challenges around relationships, sex and intimacy. From her work with individuals
0 Comments
In adults with febrile urinary tract infection (UTI), use of a “forgotten antibiotic” called temocillin led to less disturbance of the intestinal microbiota than cefotaxime, with significantly lower Enterobacterales proportions, according to a study report in The Lancet Infectious Diseases. Susceptibility to third-generation cephalosporins was also lowered in patients receiving temocillin. The rich commensal microbiota
0 Comments
Multiple myeloma is a type of cancer for which there is no cure. But treatment for this disease has improved greatly in recent years. Patients can live in remission for a long time. The man you’re about to meet was diagnosed with multiple myeloma last year, and after an intense battle, he is winning.
0 Comments
http://armandoh.org/ Describes how genes that make light and heavy chains can be randomly assorted to produce a unique type of antibody and so wil bind to a specific antigen~ https://www.facebook.com/ArmandoHasudungan Support me: http://www.patreon.com/armando Instagram: http://instagram.com/armandohasudungan Twitter: https://twitter.com/Armando71021105
0 Comments
Dr Aaron Beck Aaron Beck, MD, known as the father of cognitive behavioral therapy (CBT), died on Monday in Philadelphia. He was 100. Beck’s pioneering career in psychoanalysis spanned more than seven decades, yielding more than 600 published articles and nearly two dozen books. His development of CBT redefined the practice of psychoanalysis, challenging long-held
0 Comments
A nationwide study of over 1 million births in the English National Health Service (NHS) between 2015 and 2017, published in The Lancet, has found large inequalities in pregnancy outcomes between ethnic and socioeconomic groups in England. The findings suggest that current national programs to make pregnancy safer, which focus on individual women’s risk and
0 Comments
Cardiac parameters suggestive of myocarditis were no more common at 6 months after mild or asymptomatic COVID-19 than among people who never had the infection, a prospective case-control study found. Compared with seronegative healthcare workers, those who had generally mild SARS-CoV-2 had no differences in cardiac structure, function, MRI markers of myocarditis, or cardiac injury
0 Comments
What is open enrollment? This is the time each year when you can make changes to your health insurance coverage-usually through the Healthcare Marketplace (healthcare.gov). When can I enroll or make changes to my plan? Open enrollment for ACA (“Obamacare”) insurance plans for the 202 coverage year runs from November 1st– January 15th for states
0 Comments
A team of scientists from Israel and the USA has recently examined the efficacy of coronavirus disease 2019 (COVID-19) vaccination in reducing the death risk among people aged 70 years and above. They observe that despite government-imparted relaxation on non-pharmaceutical control measures, the vaccine saved more lives than expected by individual-level vaccine efficacy. The study
0 Comments
Steff struggled with her mental health for years, trying to find a treatment that suited her. When she finally discovered more holistic therapies, she not only began her journey to recovery, but found the inspiration to start a business to help others as well At the age of 14, I sank into a deep depression
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. With the Washington Monument in the background, people look at white flags that are part of artist Suzanne Brennan Firstenberg’s temporary art installation, “In America: Remember.” As the world nears the milestone of 5 million COVID-19 deaths, memorials large and small,
0 Comments
ORLANDO, Florida — Use of cannabis is common in patients with multiple sclerosis (MS), especially for the treatment of MS-related spasticity, new research suggests. Findings from a survey conducted through a large registry in 2020 showed that 31% of patients with MS reported trying cannabis to treat their symptoms — and 20% reported regular use.
0 Comments